SLF1 polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer

Response to oxaliplatin-based adjuvant chemotherapy varies among patients with stage II and III colon cancer; however, genetic alterations associated with this response remain incompletely characterized. A three-stage analytical framework, including the discovery, validation, and replication stages,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Cancer Res
Main Authors: Han, Xiaohong, Wang, Zheng, Zhang, Lei, Shen, Yinchen, Tan, Qiaoyun, Sun, Yongkun, Wang, Jianfei, Qian, Xiaoyan, Yang, Hongying, Shi, Yuankai
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8085871/
https://ncbi.nlm.nih.gov/pubmed/33948371
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares